NCT00255229View on ClinicalTrials.gov

Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Glutamine

Glutamine 10 g four times daily starting two days before treatment for six days in total

OTHER

Placebo

Glutamine placebo

Trial Locations (1)

T6G 1Z2

Cross Cancer Institute, Edmonton

All Listed Sponsors
collaborator

Cross Cancer Institute

OTHER

lead

AHS Cancer Control Alberta

OTHER

NCT00255229 - Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea | Biotech Hunter | Biotech Hunter